Research Profile
The hospital has outstanding research capabilities and significant characteristics. In the past five
Beijing Tiantan Hospital's Four Groundbreaking Studies Unveiled at the 2023 International Stroke Conference
The International Stroke Conference 2023 (ISC2023), held from February 8th to 10th, showcased four m
Visit of the Prof. Clay Johnston and Johnson & Johnson Delegation
On January 7, 2024, Professor Clay Johnston and a delegation from Johnson & Johnson visited the
CHANCE-3
ischemic stroke or TIA and a hsCRP level of ≥2mg/L. Patients who were eligible to the inclusion cri
TRACE-3
Official TitleA Phase 3, Multicenter, Prospective, Randomized, Open Label, Blinded-endpoint (PROBE)
INSURE
Official TitleINdobufen Versus aSpirin in acUte Ischemic stRokE（INSURE）Brief SummaryChina has the la
CHANCE-2
Official TitleClopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascula
FAVORITE
ferritin<20µg/L）or Hemoglobin deficiency(<120g/L for female and <130g/L for male).. Patie
